Your browser doesn't support javascript.
loading
Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study.
Ganser, Iris; Buckeridge, David L; Heffernan, Jane; Prague, Mélanie; Thiébaut, Rodolphe.
  • Ganser I; Univ. Bordeaux, Inserm, BPH Research Center, SISTM Team, UMR 1219 Bordeaux, France; McGill Health Informatics, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.
  • Buckeridge DL; McGill Health Informatics, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.
  • Heffernan J; Mathematics & Statistics, Centre for Disease Modelling, York University, Toronto, Ontario, Canada.
  • Prague M; Univ. Bordeaux, Inserm, BPH Research Center, SISTM Team, UMR 1219 Bordeaux, France; Inria, Inria Bordeaux - Sud-Ouest, Talence, France; Vaccine Research Institute, F-94010 Creteil, France.
  • Thiébaut R; Univ. Bordeaux, Inserm, BPH Research Center, SISTM Team, UMR 1219 Bordeaux, France; Inria, Inria Bordeaux - Sud-Ouest, Talence, France; Vaccine Research Institute, F-94010 Creteil, France; Bordeaux University Hospital, Medical Information Department, Bordeaux, France. Electronic address: rodolphe.th
Epidemics ; 46: 100744, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38324970
ABSTRACT

BACKGROUND:

Non-pharmaceutical interventions (NPIs) and vaccines have been widely used to manage the COVID-19 pandemic. However, uncertainty persists regarding the effectiveness of these interventions due to data quality issues, methodological challenges, and differing contextual factors. Accurate estimation of their effects is crucial for future epidemic preparedness.

METHODS:

To address this, we developed a population-based mechanistic model that includes the impact of NPIs and vaccines on SARS-CoV-2 transmission and hospitalization rates. Our statistical approach estimated all parameters in one step, accurately propagating uncertainty. We fitted the model to comprehensive epidemiological data in France from March 2020 to October 2021. With the same model, we simulated scenarios of vaccine rollout.

RESULTS:

The first lockdown was the most effective, reducing transmission by 84 % (95 % confidence interval (CI) 83-85). Subsequent lockdowns had diminished effectiveness (reduction of 74 % (69-77) and 11 % (9-18), respectively). A 6 pm curfew was more effective than one at 8 pm (68 % (66-69) vs. 48 % (45-49) reduction), while school closures reduced transmission by 15 % (12-18). In a scenario without vaccines before November 2021, we predicted 159,000 or 168 % (95 % prediction interval (PI) 70-315) more deaths and 1,488,000 or 300 % (133-492) more hospitalizations. If a vaccine had been available after 100 days, over 71,000 deaths (16,507-204,249) and 384,000 (88,579-1,020,386) hospitalizations could have been averted.

CONCLUSION:

Our results highlight the substantial impact of NPIs, including lockdowns and curfews, in controlling the COVID-19 pandemic. We also demonstrate the value of the 100 days objective of the Coalition for Epidemic Preparedness Innovations (CEPI) initiative for vaccine availability.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article